An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
This study has been completed.
Bellos, Nicholaos C., M.D.
Central Texas Primary Care Research Network
Orlando Immunology Center
Center for the Prevention and Treatment of Infections
Information provided by:
First received: May 8, 2008
Last updated: January 20, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2010|
|Primary Completion Date:||March 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||January 20, 2014|